US regulators on Monday authorised Pfizer and BioNTech's Covid-19 vaccine for use in children as young as 12, widening the country's inoculation programme as vaccination rates have slowed significantly.
The vaccine has been available under an emergency use authorisation (EUA) to people as young as 16 in the United States. The vaccine makers said they had started the process for full approval for those ages last week.